Skip to main content
NewslettersWatchlist

Abbott Laboratories(ABT-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low115.50
Day High121.00
Open:121.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Finish Higher on Strength in Tech Earnings
Stock Target Advisor
Market Insights & Analysis: November 1st, 2024
Barchart
Stocks Supported by Strong Amazon and Intel Earnings
Barchart
Stocks Jump on Solid Amazon Earnings and Dovish US Payroll Report
Stock Target Advisor
Market News & Analysis: October 31st, 2024
Newswire.ca
New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management
MarketBeat
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
Motley Fool
3 Dividend Growth Stocks You Can Buy and Hold Forever
Barchart
These Dividend Aristocrats Could Be a Slam Dunk in 2025
Motley Fool
Beat the Nasdaq With This Cash-Gushing Dividend Stock
Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
MarketBeat
MarketBeat Week in Review – 10/14 - 10/18
Motley Fool
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
Stock Target Advisor
Market Analysis & News: October 17th, 2024
Motley Fool
Is Abbott Laboratories Stock a Buy?
Motley Fool
Why Abbott Laboratories Stock Was a Winner on Wednesday
Motley Fool
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
MarketBeat
Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
Barchart
Stock Index Futures Steady After Yesterday’s Sell-Off, Earnings in Focus
Barchart
Stocks Set to Open Higher as Investors Await U.S. Economic Data and Corporate Earnings
Baystreet
Shortened Week in Canada Features CPI, Housing Numbers
The Globe and Mail
15 affordable long-term performers in the U.S. market

Profile

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.